Plus Therapeutics, Inc. (NASDAQ:PSTV) Q1 2024 Earnings Call Transcript May 15, 2024
Plus Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.75, expectations were $-1.09.
Operator: Good afternoon, ladies and gentlemen. Welcome to the Plus Therapeutics’ First Quarter 2024 Results Conference Call. Before we begin, we want to advise you that over the course of the call, any question-and-answer session, forward-looking statements will be made regarding events, trends, business...
